A successful demo is not a qualified opportunity. In a bank, insurer or NBFC, the distance between product enthusiasm and a purchase order is filled with business owners, architecture teams, risk, compliance, information security, procurement and investment committees.
MEDDIC forces a simple discipline: replace optimism with evidence. It asks whether the deal has a measurable outcome, a buyer with real authority, known evaluation rules, a navigable approval process, pain important enough to act on, and an insider willing to help you win.
Fintech deals do not die because the product is weak. They die because the seller never discovered how the institution buys.
M — Metrics
Turn “better” into a number the institution can defend.
Metrics connect product capability to the buyer’s operating plan: more approved customers, fewer manual reviews, lower fraud leakage, faster turnaround or additional processing capacity without another hiring cycle.
Establish the baseline, target improvement, volume affected and financial value of one improved unit. Then agree who will validate the result after implementation. If the buyer cannot explain how value will be measured, the business case is still a hypothesis.
A digital lender processes 500,000 applications a year.
- Completion rate
- 52% → 60%
- Incremental completions
- 40,000
- Disbursal rate
- 20%
- Incremental loans
- 8,000
- Contribution per loan
- ₹5,000
- Annual contribution
- ₹4 crore
E — Economic Buyer
Find the person who can fund the outcome and accept its risk.
In fintech, the CIO is often an evaluator rather than the economic buyer. The real authority usually sits with the executive who owns the P&L, cost base, regulatory exposure or transformation outcome. Your sponsor may love the platform and still lack the authority to protect its budget.
| Solution | Likely economic buyer | Primary concern |
|---|---|---|
| Digital lending | Business CEO / Head of Lending | Growth and credit quality |
| Fraud platform | CRO / Head of Fraud | Loss avoided and false positives |
| Collections AI | Head of Collections | Recovery rate and cost-to-collect |
| Voice AI | COO / Service Head | Containment, compliance and CX |
| Regulatory reporting | CFO / Compliance Head | Accuracy, control and auditability |
Economic-buyer validation means more than securing a meeting. You need explicit agreement on the problem, expected outcome, funding mechanism and decision date. If access is permanently blocked, treat that as deal risk—not a calendar inconvenience.
D — Decision Criteria
Understand the rules—and shape them before the RFP freezes.
A regulated institution rarely selects technology on product capability alone. The evaluation spans business value, architecture, compliance, security and vendor resilience. Learn which requirements are mandatory, which are weighted and which have quietly been designed around an incumbent.
ROI, adoption, time to market, flexibility and total cost
APIs, core integration, scale, availability, latency and DR
Residency, consent, explainability, audit trail and regulatory fit
References, stability, local support, roadmap and liability
If you first discover the criteria inside the RFP, another vendor may already have written the exam.
D — Decision Process
Convert institutional complexity into owners, gates and dates.
Map the formal approval path and the paper process underneath it. A fintech vendor can win the product evaluation and still miss the quarter because vendor empanelment, security exceptions, liability language or committee calendars were discovered too late.
Build a mutual action plan with one named owner and a dated exit criterion for every stage. “InfoSec review in progress” is not a plan. “CISO exception review on 24 August; evidence pack owned by the solution architect” is.
I — Identify Pain
Trace a symptom to its executive consequence.
“KYC is manual” describes a process. It does not explain why the institution must act. Strong qualification connects operational friction to business damage and then to an executive commitment.
The best urgency is tied to a forcing event: a regulatory deadline, expiring incumbent contract, board target, product launch, audit observation or visible loss of market share. Pain without consequence creates a long pipeline—not a purchase.
C — Champion
Distinguish a friendly contact from someone who will sell internally.
A champion has influence, gains from the outcome and demonstrates action. They explain how decisions are really made, expose opposition, coach you before executive meetings and advocate when you are not in the room. Enthusiasm without action is not championship.
- Will they help build the internal business case?
- Will they share the real approval sequence and political risks?
- Will they arrange access to the economic buyer?
- Will they tell you where you stand against the incumbent?
- Will they defend the decision when you are absent?
MEDDIC qualification scorecard
Score evidence—not seller confidence. Every category receives 0–3 points, producing a maximum score of 18.
Why fintech sellers should use MEDDPICC
MEDDIC is the foundation. For complex bank and insurance sales, extend it with three realities that repeatedly move closing dates.
The 12-question deal review
- 01What business metric changes if we win?
- 02What is the validated annual value?
- 03Who owns that outcome and its budget?
- 04Has the economic buyer confirmed the problem?
- 05What are the three highest-weight decision criteria?
- 06Which requirement could disqualify us?
- 07What approval gates remain, with dates and owners?
- 08When does the investment committee meet?
- 09What happens if the institution does nothing?
- 10What forcing event creates urgency?
- 11What has our champion done—not said—this week?
- 12Why will we win against the incumbent or no decision?
A forecast is a claim.
MEDDIC gives it evidence.
The goal is not to complete a CRM template. It is to expose what must become true for the institution to buy—and act on those gaps while there is still time to change the outcome.